Virtu Financial’s AYTU BioPharma AYTU Stock Holding History

Virtu Financial’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,090	Closed	-$510K	–	1499
2021 Q2	$510K	Buy	+5,090	New	+$597K	0.05%	467
2020 Q3	–	Sell	-485	Closed	-$138K	–	1053
2020 Q2	$138K	Buy	+485	New	+$147K	0.02%	804
2019 Q4	–	Sell	-149	Closed	-$36K	–	1433
2019 Q3	$36K	Buy	+149	New	+$44.9K	﹤0.01%	1236
2019 Q2	–	Sell	-89	Closed	-$30K	–	1456
2019 Q1	$30K	Buy	+89	New	+$22.2K	﹤0.01%	1260
2018 Q3	–	Sell	-9	Closed	-$10K	–	1536
2018 Q2	$10K	Buy	+9	New	+$15K	﹤0.01%	1903

Other funds holding AYTU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's AYTU Position: Q3 2021 in Review

Virtu Financial sold out of AYTU BioPharma (AYTU) in Q3 2021, closing a stake of 5,090 shares — an estimated $510K sold.

Virtu Financial first reported a position in AYTU in Q2 2018 and held it in 5 quarters. The position peaked at $510K in Q2 2021. 39 funds tracked by Wall St. Rank hold AYTU as of Q3 2021.

Virtu Financial reported no remaining AYTU BioPharma position as of Q3 2021 after selling out during the quarter.
Virtu Financial sold 5,090 AYTU BioPharma shares in Q3 2021, an estimated $510K.
Virtu Financial first reported a position in AYTU BioPharma in Q2 2018 and held it in 5 quarters.
Virtu Financial's AYTU BioPharma position peaked at $510K in Q2 2021.
39 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.